Drug factory · FDA FEI 3002806993
Forest Laboratories Ireland Limited
Clonshaugh Business & Technology, Clonshaugh, Dublin 17, , Dublin, Ireland
Problems found, fixed voluntarily at FDA's last inspection, Apr 14, 2022.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
7 drug inspections on record since 2010: 2 with no problems, 5 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Milnacipran | Makes it and tests it | Glenmark Pharmaceuticals Inc., USA | 68462-763, 68462-764, 68462-765 +1 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Apr 14, 2022 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 7, 2020 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 10, 2017 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 5, 2015 | No problems found | Drug Quality Assurance | — |
| Mar 26, 2013 | No problems found | Drug Quality Assurance | — |
| Nov 18, 2011 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 25, 2010 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; manufacture.